Outcomes of autologous bone marrow mononuclear cell transplantation in decompensated liver cirrhosis

Table 1 Comparison of clinical and laboratory parameters between the two groups before transplantation

Parameter	Control	BM-MNCs	Pvalue
Patient (n)	15	32	ND
Age (yr)	47.4 ± 11.1	46.4 ± 11.6	0.8542
Gender
Male	9	20
Female	6	12	0.8691
HBsAg
Positive	13	30
Negative	2	2	0.5833
Liver function
Alanine aminotransferase (IU/L)	51.7 ± 14.5	53.2 ± 13.5	0.7342
Aspartate aminotransferase (IU/L)	63.7 ± 14.4	67.9 ± 16.7	0.4042
Serum albumin (g/L)	28.1 ± 2.8	27.9 ± 2.5	0.7962
Prealbumin (mg/L)	85.1 ± 23.5	83.5 ± 22.4	0.8192
Total bilirubin (mmol/L)	53.5 ± 17.9	52.2 ± 13.4	0.7722
Coagulation function
Prothrombin time (s)	16.3 ± 3.0	16.9 ± 2.3	0.4372
Prothrombin activity	71.8% ± 19.4%	67.8% ± 15.0%	0.4372
Fibrinogen (g/L)	1.83 ± 0.53	1.81 ± 0.52	0.8642
Routine blood indices
White blood cell counts (× 109/L)	2.83 ± 1.07	2.73 ± 0.84	0.7212
Hemoglobin (g/L)	107.8 ± 11.4	105.9 ± 12.6	0.6242
Platelet counts (× 109/L)	69.0 ± 16.6	67.2 ± 15.5	0.7172

Data are expressed as the mean ± SD.

¹Pearson χ² test;

²t test;

³Fisher’s exact test. BM-MNCs: Bone marrow mononuclear cells; HBsAg: Hepatitis B surface antigen; ND: No data.